Loading…
Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia
To evaluate the 12-months outcomes of photorefractive keratectomy (PRK) in patients with high myopia (≥ 6.0 diopters, D) compared with low-to-moderate myopia (< 6.0 D). Records of 46 patients (69 eyes) who underwent PRK for myopic and astigmatic correction between October 2015 and December 2018 w...
Saved in:
Published in: | Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2021-01, Vol.15, p.4775-4785 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3 |
container_end_page | 4785 |
container_issue | |
container_start_page | 4775 |
container_title | Clinical ophthalmology (Auckland, N.Z.) |
container_volume | 15 |
creator | Tananuvat, Napaporn Winaikosol, Pawara Niparugs, Muanploy Chaidaroon, Winai Tangmonkongvoragul, Chulaluck Ausayakhun, Somsanguan |
description | To evaluate the 12-months outcomes of photorefractive keratectomy (PRK) in patients with high myopia (≥ 6.0 diopters, D) compared with low-to-moderate myopia (< 6.0 D).
Records of 46 patients (69 eyes) who underwent PRK for myopic and astigmatic correction between October 2015 and December 2018 were reviewed. High myopic eyes (29 eyes) were compared with low-to-moderate myopic eyes (40 eyes). All surgeries were adjunct with 0.02% mitomycin C intraoperatively. Measured outcomes included postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent, corneal haze rate, and any complications.
At 12 months post-PRK, 26 eyes (89.7%) in the high myopia and 39 eyes (97.5%) in the low-to-moderate myopia group had UDVA ≥ 20/20, (p=0.30). Average postoperative logMAR UDVA at 12 months was -0.04 (20/18) and -0.11 (20/15) for the high myopia and low-to-moderate myopia groups, respectively. No eyes in either group had residual refractive errors >1 D. No eyes in both groups developed significant corneal haze at month 12. No eyes had a loss of greater than two Snellen lines of CDVA at 12 months post-surgery. The efficacy and safety indices at 12 months post-surgery were not significantly different between groups (1.06±0.26 vs.1.14±0.27, p =0.25 and 1.14±0.27 vs 1.17±0.26, p=0.60 for low-to-moderate myopia vs high myopia groups, respectively).
PRK with high myopic correction provides excellent refractive outcomes and is safe, compared to those of low-to-moderate myopic correction. |
doi_str_mv | 10.2147/OPTH.S346992 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8f436521759f44afb99829d2511a8286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689995302</galeid><doaj_id>oai_doaj_org_article_8f436521759f44afb99829d2511a8286</doaj_id><sourcerecordid>A689995302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3</originalsourceid><addsrcrecordid>eNptkk2P0zAQhiMEYpfCjTOKhIQ4kBJ_xB8XpFUFdEVXXYkijpbjOI1XSaY4bqvyG_jRuNtStgj5YGvmmXfs8ZskL1E-xojy9_PbxXT8lVAmJX6UXCLEeVZQQR6fzoxfJM-G4S7PGc4Ff5pckAJjxJi8TH4ttrbd2OwG-tCk83Uw0NkhhToNjU2_642tfUxl81Vwnftpq_S2gQA-hrUJbmPTL9brYE2AbpfW4NOpWzbpzQ5WzqQT8D6mHPTx2K20j_VbFxvNYJsFiF2r--oDr58nT2rdDvbFcR8l3z59XEym2Wz--XpyNctMwVnIqrwuyqrSJZKICypLZgjDnEpBtNRIICtZyYucU2MZFSXiJcpLQmIN17aoySi5PuhWoO_UyrtO-50C7dR9APxSaR-caa0SNSWswIgXsqZU16WUAssKFwhpgQWLWh8OWqt12dnK2D543Z6Jnmd616glbJQQ8QPilUfJ26OAhx9rOwTVucHYttW9hfWgMCO0iG8TPKKv_0HvYO37OKpI4RxjTDH7Sy11fIDra4h9zV5UXTEhpSxIjiM1_g8VV2U7Z6C3tYvxs4I3Dwoaq9vQDNCu9787nIPvDqDxMAzRKadhoFztLav2llVHy0b81cMBnuA_HiW_AeYa5pc</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620222426</pqid></control><display><type>article</type><title>Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia</title><source>Publicly Available Content Database</source><source>Taylor & Francis Open Access Journals</source><source>PubMed Central</source><creator>Tananuvat, Napaporn ; Winaikosol, Pawara ; Niparugs, Muanploy ; Chaidaroon, Winai ; Tangmonkongvoragul, Chulaluck ; Ausayakhun, Somsanguan</creator><creatorcontrib>Tananuvat, Napaporn ; Winaikosol, Pawara ; Niparugs, Muanploy ; Chaidaroon, Winai ; Tangmonkongvoragul, Chulaluck ; Ausayakhun, Somsanguan</creatorcontrib><description>To evaluate the 12-months outcomes of photorefractive keratectomy (PRK) in patients with high myopia (≥ 6.0 diopters, D) compared with low-to-moderate myopia (< 6.0 D).
Records of 46 patients (69 eyes) who underwent PRK for myopic and astigmatic correction between October 2015 and December 2018 were reviewed. High myopic eyes (29 eyes) were compared with low-to-moderate myopic eyes (40 eyes). All surgeries were adjunct with 0.02% mitomycin C intraoperatively. Measured outcomes included postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent, corneal haze rate, and any complications.
At 12 months post-PRK, 26 eyes (89.7%) in the high myopia and 39 eyes (97.5%) in the low-to-moderate myopia group had UDVA ≥ 20/20, (p=0.30). Average postoperative logMAR UDVA at 12 months was -0.04 (20/18) and -0.11 (20/15) for the high myopia and low-to-moderate myopia groups, respectively. No eyes in either group had residual refractive errors >1 D. No eyes in both groups developed significant corneal haze at month 12. No eyes had a loss of greater than two Snellen lines of CDVA at 12 months post-surgery. The efficacy and safety indices at 12 months post-surgery were not significantly different between groups (1.06±0.26 vs.1.14±0.27, p =0.25 and 1.14±0.27 vs 1.17±0.26, p=0.60 for low-to-moderate myopia vs high myopia groups, respectively).
PRK with high myopic correction provides excellent refractive outcomes and is safe, compared to those of low-to-moderate myopic correction.</description><identifier>ISSN: 1177-5467</identifier><identifier>ISSN: 1177-5483</identifier><identifier>EISSN: 1177-5483</identifier><identifier>DOI: 10.2147/OPTH.S346992</identifier><identifier>PMID: 35221669</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Ablation ; Comparative analysis ; Contact lenses ; Cornea ; corneal haze ; high myopia ; Iris ; Laboratories ; Lasers ; Mitomycin ; Myopia ; Nepafenac ; Normal distribution ; Original Research ; Patient outcomes ; Photorefractive keratectomy ; prk ; refractive surgery ; Surgery ; Topography ; wavefront-optimized</subject><ispartof>Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.4775-4785</ispartof><rights>2021 Tananuvat et al.</rights><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><rights>2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Tananuvat et al. 2021 Tananuvat et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3</citedby><cites>FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3</cites><orcidid>0000-0003-4124-9163 ; 0000-0003-2254-2532</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2620222426/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2620222426?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35221669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tananuvat, Napaporn</creatorcontrib><creatorcontrib>Winaikosol, Pawara</creatorcontrib><creatorcontrib>Niparugs, Muanploy</creatorcontrib><creatorcontrib>Chaidaroon, Winai</creatorcontrib><creatorcontrib>Tangmonkongvoragul, Chulaluck</creatorcontrib><creatorcontrib>Ausayakhun, Somsanguan</creatorcontrib><title>Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia</title><title>Clinical ophthalmology (Auckland, N.Z.)</title><addtitle>Clin Ophthalmol</addtitle><description>To evaluate the 12-months outcomes of photorefractive keratectomy (PRK) in patients with high myopia (≥ 6.0 diopters, D) compared with low-to-moderate myopia (< 6.0 D).
Records of 46 patients (69 eyes) who underwent PRK for myopic and astigmatic correction between October 2015 and December 2018 were reviewed. High myopic eyes (29 eyes) were compared with low-to-moderate myopic eyes (40 eyes). All surgeries were adjunct with 0.02% mitomycin C intraoperatively. Measured outcomes included postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent, corneal haze rate, and any complications.
At 12 months post-PRK, 26 eyes (89.7%) in the high myopia and 39 eyes (97.5%) in the low-to-moderate myopia group had UDVA ≥ 20/20, (p=0.30). Average postoperative logMAR UDVA at 12 months was -0.04 (20/18) and -0.11 (20/15) for the high myopia and low-to-moderate myopia groups, respectively. No eyes in either group had residual refractive errors >1 D. No eyes in both groups developed significant corneal haze at month 12. No eyes had a loss of greater than two Snellen lines of CDVA at 12 months post-surgery. The efficacy and safety indices at 12 months post-surgery were not significantly different between groups (1.06±0.26 vs.1.14±0.27, p =0.25 and 1.14±0.27 vs 1.17±0.26, p=0.60 for low-to-moderate myopia vs high myopia groups, respectively).
PRK with high myopic correction provides excellent refractive outcomes and is safe, compared to those of low-to-moderate myopic correction.</description><subject>Ablation</subject><subject>Comparative analysis</subject><subject>Contact lenses</subject><subject>Cornea</subject><subject>corneal haze</subject><subject>high myopia</subject><subject>Iris</subject><subject>Laboratories</subject><subject>Lasers</subject><subject>Mitomycin</subject><subject>Myopia</subject><subject>Nepafenac</subject><subject>Normal distribution</subject><subject>Original Research</subject><subject>Patient outcomes</subject><subject>Photorefractive keratectomy</subject><subject>prk</subject><subject>refractive surgery</subject><subject>Surgery</subject><subject>Topography</subject><subject>wavefront-optimized</subject><issn>1177-5467</issn><issn>1177-5483</issn><issn>1177-5483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk2P0zAQhiMEYpfCjTOKhIQ4kBJ_xB8XpFUFdEVXXYkijpbjOI1XSaY4bqvyG_jRuNtStgj5YGvmmXfs8ZskL1E-xojy9_PbxXT8lVAmJX6UXCLEeVZQQR6fzoxfJM-G4S7PGc4Ff5pckAJjxJi8TH4ttrbd2OwG-tCk83Uw0NkhhToNjU2_642tfUxl81Vwnftpq_S2gQA-hrUJbmPTL9brYE2AbpfW4NOpWzbpzQ5WzqQT8D6mHPTx2K20j_VbFxvNYJsFiF2r--oDr58nT2rdDvbFcR8l3z59XEym2Wz--XpyNctMwVnIqrwuyqrSJZKICypLZgjDnEpBtNRIICtZyYucU2MZFSXiJcpLQmIN17aoySi5PuhWoO_UyrtO-50C7dR9APxSaR-caa0SNSWswIgXsqZU16WUAssKFwhpgQWLWh8OWqt12dnK2D543Z6Jnmd616glbJQQ8QPilUfJ26OAhx9rOwTVucHYttW9hfWgMCO0iG8TPKKv_0HvYO37OKpI4RxjTDH7Sy11fIDra4h9zV5UXTEhpSxIjiM1_g8VV2U7Z6C3tYvxs4I3Dwoaq9vQDNCu9787nIPvDqDxMAzRKadhoFztLav2llVHy0b81cMBnuA_HiW_AeYa5pc</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Tananuvat, Napaporn</creator><creator>Winaikosol, Pawara</creator><creator>Niparugs, Muanploy</creator><creator>Chaidaroon, Winai</creator><creator>Tangmonkongvoragul, Chulaluck</creator><creator>Ausayakhun, Somsanguan</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4124-9163</orcidid><orcidid>https://orcid.org/0000-0003-2254-2532</orcidid></search><sort><creationdate>20210101</creationdate><title>Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia</title><author>Tananuvat, Napaporn ; Winaikosol, Pawara ; Niparugs, Muanploy ; Chaidaroon, Winai ; Tangmonkongvoragul, Chulaluck ; Ausayakhun, Somsanguan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Comparative analysis</topic><topic>Contact lenses</topic><topic>Cornea</topic><topic>corneal haze</topic><topic>high myopia</topic><topic>Iris</topic><topic>Laboratories</topic><topic>Lasers</topic><topic>Mitomycin</topic><topic>Myopia</topic><topic>Nepafenac</topic><topic>Normal distribution</topic><topic>Original Research</topic><topic>Patient outcomes</topic><topic>Photorefractive keratectomy</topic><topic>prk</topic><topic>refractive surgery</topic><topic>Surgery</topic><topic>Topography</topic><topic>wavefront-optimized</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tananuvat, Napaporn</creatorcontrib><creatorcontrib>Winaikosol, Pawara</creatorcontrib><creatorcontrib>Niparugs, Muanploy</creatorcontrib><creatorcontrib>Chaidaroon, Winai</creatorcontrib><creatorcontrib>Tangmonkongvoragul, Chulaluck</creatorcontrib><creatorcontrib>Ausayakhun, Somsanguan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Proquest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tananuvat, Napaporn</au><au>Winaikosol, Pawara</au><au>Niparugs, Muanploy</au><au>Chaidaroon, Winai</au><au>Tangmonkongvoragul, Chulaluck</au><au>Ausayakhun, Somsanguan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia</atitle><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle><addtitle>Clin Ophthalmol</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>15</volume><spage>4775</spage><epage>4785</epage><pages>4775-4785</pages><issn>1177-5467</issn><issn>1177-5483</issn><eissn>1177-5483</eissn><abstract>To evaluate the 12-months outcomes of photorefractive keratectomy (PRK) in patients with high myopia (≥ 6.0 diopters, D) compared with low-to-moderate myopia (< 6.0 D).
Records of 46 patients (69 eyes) who underwent PRK for myopic and astigmatic correction between October 2015 and December 2018 were reviewed. High myopic eyes (29 eyes) were compared with low-to-moderate myopic eyes (40 eyes). All surgeries were adjunct with 0.02% mitomycin C intraoperatively. Measured outcomes included postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent, corneal haze rate, and any complications.
At 12 months post-PRK, 26 eyes (89.7%) in the high myopia and 39 eyes (97.5%) in the low-to-moderate myopia group had UDVA ≥ 20/20, (p=0.30). Average postoperative logMAR UDVA at 12 months was -0.04 (20/18) and -0.11 (20/15) for the high myopia and low-to-moderate myopia groups, respectively. No eyes in either group had residual refractive errors >1 D. No eyes in both groups developed significant corneal haze at month 12. No eyes had a loss of greater than two Snellen lines of CDVA at 12 months post-surgery. The efficacy and safety indices at 12 months post-surgery were not significantly different between groups (1.06±0.26 vs.1.14±0.27, p =0.25 and 1.14±0.27 vs 1.17±0.26, p=0.60 for low-to-moderate myopia vs high myopia groups, respectively).
PRK with high myopic correction provides excellent refractive outcomes and is safe, compared to those of low-to-moderate myopic correction.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>35221669</pmid><doi>10.2147/OPTH.S346992</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-4124-9163</orcidid><orcidid>https://orcid.org/0000-0003-2254-2532</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1177-5467 |
ispartof | Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.4775-4785 |
issn | 1177-5467 1177-5483 1177-5483 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_8f436521759f44afb99829d2511a8286 |
source | Publicly Available Content Database; Taylor & Francis Open Access Journals; PubMed Central |
subjects | Ablation Comparative analysis Contact lenses Cornea corneal haze high myopia Iris Laboratories Lasers Mitomycin Myopia Nepafenac Normal distribution Original Research Patient outcomes Photorefractive keratectomy prk refractive surgery Surgery Topography wavefront-optimized |
title | Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A56%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Twelve-Month%20Outcomes%20of%20the%20Wavefront-Optimized%20Photorefractive%20Keratectomy%20for%20High%20Myopic%20Correction%20Compared%20with%20Low-to-Moderate%20Myopia&rft.jtitle=Clinical%20ophthalmology%20(Auckland,%20N.Z.)&rft.au=Tananuvat,%20Napaporn&rft.date=2021-01-01&rft.volume=15&rft.spage=4775&rft.epage=4785&rft.pages=4775-4785&rft.issn=1177-5467&rft.eissn=1177-5483&rft_id=info:doi/10.2147/OPTH.S346992&rft_dat=%3Cgale_doaj_%3EA689995302%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-d0f5bddab1917849b6c36274983a9a181e96b75074ce648b17b10b33bdd7ae5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2620222426&rft_id=info:pmid/35221669&rft_galeid=A689995302&rfr_iscdi=true |